Literature DB >> 19471116

Tunnelling nanotubes: a highway for prion spreading?

Karine Gousset1, Chiara Zurzolo.   

Abstract

The discovery of tunnelling nanotubes (TNTs) and their proposed role in long intercellular transport of organelles, bacteria and viruses have led us to examine their potential role during prion spreading. We have recently shown that these membrane bridges can form between neuronal cells, as well as between dendritic cells and primary neurons and that both endogenous and exogenous PrP(Sc) appear to traffic through these structures between infected and non-infected cells. Furthermore, prion infection can be efficiently transmitted from infected dendritic cells to primary neurons only in co-culture conditions permissive for TNT formation. Therefore, we propose a role for TNTs during prion spreading from the periphery to the central nervous system (CNS). Here, we discuss some of the key steps where TNTs might play a role during prion neuroinvasion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19471116      PMCID: PMC2712606          DOI: 10.4161/pri.3.2.8917

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  53 in total

1.  CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance.

Authors:  Jan Hendrik Niess; Stephan Brand; Xiubin Gu; Limor Landsman; Steffen Jung; Beth A McCormick; Jatin M Vyas; Marianne Boes; Hidde L Ploegh; James G Fox; Dan R Littman; Hans-Christian Reinecker
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

2.  Interfaces between dendritic cells, other immune cells, and nerve fibres in mouse Peyer's patches: potential sites for neuroinvasion in prion diseases.

Authors:  Valérie Defaweux; Gauthier Dorban; Caroline Demonceau; Joëlle Piret; Olivier Jolois; Olivier Thellin; Caroline Thielen; Ernst Heinen; Nadine Antoine
Journal:  Microsc Res Tech       Date:  2005-01-01       Impact factor: 2.769

3.  Functional connectivity between immune cells mediated by tunneling nanotubules.

Authors:  Simon C Watkins; Russell D Salter
Journal:  Immunity       Date:  2005-09       Impact factor: 31.745

Review 4.  Cellular biology of prion diseases.

Authors:  D A Harris
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

5.  Packaging of prions into exosomes is associated with a novel pathway of PrP processing.

Authors:  L J Vella; R A Sharples; V A Lawson; C L Masters; R Cappai; A F Hill
Journal:  J Pathol       Date:  2007-04       Impact factor: 7.996

6.  Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission.

Authors:  Nathan M Sherer; Maik J Lehmann; Luisa F Jimenez-Soto; Christina Horensavitz; Marc Pypaert; Walther Mothes
Journal:  Nat Cell Biol       Date:  2007-02-11       Impact factor: 28.824

7.  Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells.

Authors:  Ana Cristina Magalhães; Gerald S Baron; Kil Sun Lee; Olivia Steele-Mortimer; David Dorward; Marco A M Prado; Byron Caughey
Journal:  J Neurosci       Date:  2005-05-25       Impact factor: 6.167

8.  Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res.

Authors:  Gerald S Baron; Ana C Magalhães; Marco A M Prado; Byron Caughey
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Follicular dendritic cell dedifferentiation reduces scrapie susceptibility following inoculation via the skin.

Authors:  Joanne Mohan; Moira E Bruce; Neil A Mabbott
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

Review 10.  Prions and their lethal journey to the brain.

Authors:  Neil A Mabbott; G Gordon MacPherson
Journal:  Nat Rev Microbiol       Date:  2006-03       Impact factor: 60.633

View more
  42 in total

1.  Tunneling-nanotube development in astrocytes depends on p53 activation.

Authors:  Y Wang; J Cui; X Sun; Y Zhang
Journal:  Cell Death Differ       Date:  2010-11-26       Impact factor: 15.828

Review 2.  Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics.

Authors:  Anuradha Kalani; Alka Tyagi; Neetu Tyagi
Journal:  Mol Neurobiol       Date:  2013-09-03       Impact factor: 5.590

3.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

4.  Tunneling-nanotube: A new way of cell-cell communication.

Authors:  Yan Zhang
Journal:  Commun Integr Biol       Date:  2011-05

Review 5.  Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.

Authors:  Ines Moreno-Gonzalez; Claudio Soto
Journal:  Semin Cell Dev Biol       Date:  2011-05-05       Impact factor: 7.727

6.  Prion Efficiently Replicates in α-Synuclein Knockout Mice.

Authors:  Edoardo Bistaffa; Martina Rossi; Chiara Maria Giulia De Luca; Federico Cazzaniga; Olga Carletta; Ilaria Campagnani; Fabrizio Tagliavini; Giuseppe Legname; Giorgio Giaccone; Fabio Moda
Journal:  Mol Neurobiol       Date:  2019-04-30       Impact factor: 5.590

7.  Tunneling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target?

Authors:  Varun Subramaniam Venkatesh; Emil Lou
Journal:  Cancer Rep (Hoboken)       Date:  2019-05-08

8.  Coinfecting prion strains compete for a limiting cellular resource.

Authors:  Ronald A Shikiya; Jacob I Ayers; Charles R Schutt; Anthony E Kincaid; Jason C Bartz
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

9.  Tunneling nanotubes between rat primary astrocytes and C6 glioma cells alter proliferation potential of glioma cells.

Authors:  Lei Zhang; Yan Zhang
Journal:  Neurosci Bull       Date:  2015-04-26       Impact factor: 5.203

10.  GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells.

Authors:  Jonathan O Speare; Danielle K Offerdahl; Aaron Hasenkrug; Aaron B Carmody; Gerald S Baron
Journal:  EMBO J       Date:  2010-01-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.